Pancreatic Cancer Resists Personalized Medicine—What Researchers are Doing to Fight Back

LW Newsfeed
A team led by University of Arizona researchers is taking a new, patient-directed approach to treating pancreatic cancer.

Rather than relying on conventional cell lines that have defined effective drug targets for other types of cancers, they are creating and sequencing cell lines from a cancer patient’s own tissue. Their results, outlined August 4 in Cell Reports, reveal that pancreatic tumors are more varied than previously thought and that drug sensitivity is unique to each patient. Read more . . .

image_printPrint Page

Conversation